Reumatominas
Neste episódio, contamos com a participação das reumatologistas Dra. Joana Starling, mestre em ciências aplicadas a saúde do adulto pela UFMG, e Dra. Gilda Ferreira, coordenadora do serviço de reumatologia do hospital das clinicas da UFMG, para falar sobre uma das principais causas de mortalidade no Lupus Eritematoso Sistêmico: as infecções.
Referências:
1) Flare x Infecção
- Ospina FE, Echeverri A, Zambrano D, et al. Distinguishing infections vs flares in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2016.
2) Curva de PCR
-Borges I, Carneiro R, Bergo R, et al. Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers. Crit Care. 2020;24(1):281.
3) Infecções no LES
- Feldman CH, Hiraki LT, Winkelmayer WC, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015;67(6):1577-85. 47.
- Goldblatt F, Chambers S, Rahman A, et al. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18(8):682-9. 48.
-Bernal-Macias S, Reyes-Beltran B, Molano-Gonzalez N, et al. Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med. 2015;2(1):e000122. 49. Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013;22(12):1286-94.